I'd like to apply for this job kokum butter skin recipes Daiichi Sankyo is also testing the drug in patients with aheart rhythm disorder called atrial fibrillation, to preventblood clots from forming in the heart. If it’s approved in bothgroups of patients, sales of edoxaban are expected to reach 40billion yen by the year ending March 2018, according to SMBCNikko Securities Inc.